EUSOI European Society of Ocular Inflammation

EUSOI Meeting 2026

European Society of Ocular Inflammation

Friday, 4 September 2026

Foundations and Current Practice

12:30 – 13:30
Lunch Symposium (Roche)
Targeting Novel Immune Pathways in Ocular Inflammation
Vamikibart: Mechanism and Clinical Development

13:30 – 14:00
Registration

14:00 – 14:15
Welcome & Opening Remarks

  • Carlos Pavesio (President, EUSOI)
  • Objectives & Vision for European Collaboration

14:15 – 15:15

Session 1: Systemic Therapy in Uveitis – European Perspective

Chairs: Joke de Boer, Gilles Kaplanski

  • Corticosteroids: Benefits & Risks – Natasa Vidovic
  • DMARDs in Uveitis – Mirjam van Velthoven
  • Biological Era – Young Ophthalmologists’ View – Charlotte van Meerwijk
  • Early vs Late Biologics – Senior Perspective – Marc de Smet

Discussion

15:15 – 15:45
Coffee Break

15:45 – 16:45

Session 2: Local Therapies in Uveitis

Chair: Carlos Pavesio

  • Keynote: Piergiorgio Neri
  • Case 1: UME – Alessandro Invernizzi
  • Case 2: PIC/MFC – Ilaria Testi
  • Case 3: Retinal Vasculitis – Elisabetta Miserocchi

Discussion

16:45 – 17:45

Session 3: Complex Decision-Making in Uveitis

Chairs: Sofia Androudi, Jarmila Heissigerova

  • Keynote: Diagnostic Strategies – Sara Touhami
  • Masquerade Syndrome – Zohar Habot-Wilner
  • Autoimmune Uveitis – I. Papasavas
  • Infectious Uveitis – Aniruddha Agarwal

Panel Discussion:
Siham Chariba, Cherif Titah, François Willermain

17:45
End of Day 1

Saturday, 5 September 2026

Advanced Therapies, Imaging and the Future

08:30 – 09:30

Session 4: Biologic Therapy in Uveitis

Chairs: Bahram Bodaghi, David Saadoun

  • Keynote: Update & Perspectives – David Saadoun
  • Cases: I. Leal, C. Titah, W. Tucker

Discussion Panel:
A. Adan, P. Neri, I. Testi, Y. El Shabrawy

09:30 – 10:30

Session 5: Imaging in Ocular Inflammation

Chairs: Elisabetta Miserocchi, Bahram Bodaghi

  • Multimodal Imaging – Luca De Simone
  • OCT Biomarkers – Prithvi Ramthoul
  • Widefield Angiography – Ester Carreno
  • Choroidal Imaging – Maria Vittoria Cicinelli
  • Imaging Endpoints in Trials – Alessandro Marchese

Interactive Discussion

10:30 – 10:45
Coffee Break

10:45 – 11:45

Session 6: Orbital Inflammation, Optic Neuritis & Scleritis

Chairs: Carlos Pavesio, Valerie Touitou

  • Thyroid Eye Disease – Jimmy Uddin
  • IgG4 Orbital Disease – Federico Maestri
  • Scleritis – Julie Gueudry
  • Noninfectious Optic Neuritis – Valerie Touitou
  • Multidisciplinary Management

Discussion

11:45 – 12:45

Session 7: Ocular Surface Inflammation & Dry Eye

  • Dry Eye in Autoimmune Disease – Christophe Baudouin
  • Inflammation Mechanisms – Christophe Baudouin
  • Allergy vs Dry Eye Mechanisms – TBD
  • Biomarkers – Marlies Gijs
  • Microbiota – Marc Labetoulle

Discussion

12:45 – 13:45
Industry Lunch Symposium (Alimera)
Long-Acting Intravitreal Therapy in Non-Infectious Uveitis
Outcomes with Iluvien

13:45 – 14:45

Session 8: Emerging Therapies & Pipeline

Chairs: Alex Fonollosa, David Saadoun

  • Precision Immune Modulation – Colin Chu
  • Tulisokibart (TL1A) – Laurent Peyrin-Biroulet
  • Brepocitinib (TYK2/JAK1) – Elena Bolletta
  • Bimekizumab (IL-17A/F) – Carmen Secada
  • Port-Delivery Platform – Aude Couturier

Panel: Systemic vs Local Therapies

14:45 – 15:45

Session 9: European Research Priorities & Strategy

Leads: Talin Barisani-Asenbauer, Carsten Heinz

Outputs:

  • Survey Results
  • Priority Topics
  • Breakout Discussions
  • Consensus & Action Plan

➡ Deliverable: EUSOI Research Roadmap 2026–2028

15:45 – 16:00
Coffee Break

16:00 – 17:00

Session 10: EUSOI Society Session

Executive Board

  • Strategic Outcomes
  • Governance & Committees
  • Education & Fellowships
  • Roadmap 2026–2028
  • Member Engagement

17:00

Closing Remarks